Actividades preventivas en la mujer. Actualización PAPPS 2024

Actividades preventivas en la mujer. Actualización PAPPS 2024

Resumen: En la actualización del PAPPS de 2024 presentamos aquellas actividades preventivas específicas para la salud de la mujer, exceptuando las relacionadas con la prevención del cáncer (que se incluye en otro documento) y los aspectos relacionados con la morbilidad diferencial de género, aspecto...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alberto López García-Franco, Pablo Alonso-Coello, Ana Pereira Iglesias, Cristina González Fernádez, Elisa Romero Pineda, Jacinta Landa Goñi
Format:	Article
Language:	Spanish
Published:	Elsevier 2024-11-01
Series:	Atención Primaria
Subjects:	Postmenopausal osteoporosis Contraceptive agents Pregnancy Preventive health service
Online Access:	http://www.sciencedirect.com/science/article/pii/S0212656724002737
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Actividades preventivas en el mayor. Actualización PAPPS 2024
by: Rosa Ana García Pliego, et al.
Published: (2024-11-01)

Recomendaciones preventivas vasculares. Actualización PAPPS 2024
by: Domingo Orozco-Beltrán, et al.
Published: (2024-11-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Quality use of medicines: The postmenopausal woman with osteoporosis
by: Andy Gray, et al.
Published: (2003-05-01)

EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
by: Evgeni Germanovich Zotkin
Published: (2010-06-01)

Estimation of Some Biomarkers Related to Bone Turnover in Iraqi Women
by: Wafaa Raji Alfatlawi
Published: (2025-04-01)

The Evaluation of Efficacy of Calcitriol on Bone Mineral Density, Pain and Quality of Life in Postmenopausal Osteoporotic Patients With or Without Depression
by: Halil Koyuncu, et al.
Published: (2003-12-01)

Strontium Ranelate: The First Dual Action Bone Agent
by: R. Chunder
Published: (2006-07-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

The application of FRAX values to determine the distribution of risk factors for Osteoporosis in Postmenopausal women
by: Tri Hari Irfani
Published: (2016-03-01)

THE COMPARISON OF PLASMA MALONDIALDEHYDE LEVELS AMONG OSTEOPOROTIC AND NON-OSTEOPOROTIC POSTMENOPAUSAL WOMEN
by: Innawati Jusup, et al.
Published: (2020-11-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)

Examining the association between genetic polymorphisms and osteoporosis among post-menopausal women: a systematic review
by: Zainab Alhalwachi, et al.
Published: (2025-01-01)

Osteoporosis and cardiovascular diseases
by: S G Anikin, et al.
Published: (2009-08-01)

Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis
by: Yuwangxuan Qian, et al.
Published: (2025-02-01)

Gynoid lean muscle mass as mediator between menarche age, hand grip and bone mineral density in postmenopausal women
by: Miyang Xu, et al.
Published: (2025-05-01)

Ovariectomy-induced bone loss through inappropriate inflammatory response: an osteoimmunological perspective on postmenopausal osteoporosis
by: Lilika Higuchi, et al.
Published: (2025-05-01)

Osteoporosis-related knowledge among Serbian postmenopausal women
by: Vujasinović-Stupar Nada, et al.
Published: (2017-01-01)

Effects of key physiological parameters on cardiovascular disease and osteoporosis risk in perimenopausal and postmenopausal women
by: Hong Mou, et al.
Published: (2025-01-01)

Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

RISK ASSESSMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Z. Shukerova
Published: (2020-12-01)

Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression
by: Xiu C, et al.
Published: (2025-06-01)

MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW
by: V A Myakotkin, et al.
Published: (2011-04-01)

Vitamin D and calcium supplementation in women undergoing pharmacological management for postmenopausal osteoporosis: a level I of evidence systematic review
by: Filippo Migliorini, et al.
Published: (2025-03-01)

The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study
by: Miao Zheng, et al.
Published: (2025-06-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01)

Evaluation of relationship between SPON1 gene and genetic susceptibility of postmenopausal osteoporosis
by: Wenlong Ma, et al.
Published: (2020-01-01)

Tangeretin suppresses RANKL-induced osteoclastogenesis and alleviates postmenopausal osteoporosis by inhibiting Notch signaling
by: Tengfei Wu, et al.
Published: (2025-12-01)

Radiomics based on lumbar CT to identify high-risk patients for OVCF in postmenopausal women
by: Qingsong Yu, et al.
Published: (2025-06-01)

Pathogenetic mechanisms of postmenopausal osteoporosis formation and their relationship with cardiovascular pathology
by: G. V. Poryadin, et al.
Published: (2022-04-01)

Bioinformatics analysis of Rho-signal transduction genes in postmenopausal osteoporosis and periodontitis
by: Jing Qi, et al.
Published: (2025-08-01)

Analysis of mandible trabecular structure using digital periapical radiographs to assess low bone quality in postmenopausal women
by: Silviana Farrah Diba, et al.
Published: (2021-12-01)

Efficient evaluation of osteotoxicity and mechanisms of endocrine disrupting chemicals using network toxicology and molecular docking approaches: triclosan as a model compound
by: Zhongyuan Wang, et al.
Published: (2025-03-01)

The role of dietary inflammation in the risk of osteoporosis in Iranian postmenopausal women: a case-control study
by: Marzieh Ghadiri, et al.
Published: (2025-02-01)

Serum interleukin-17 expression in postmenopausal women and its relation to osteoporosis and risk of fractures
by: Samar G. Soliman, et al.
Published: (2025-01-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

Prevention of osteoporosis in ovariectomized mice with calcium yak caseinate
by: Lijing Yang, et al.
Published: (2025-05-01)

Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis
by: K A Maslova, et al.
Published: (2008-06-01)

Discussion on Research Approaches of Traditional Chinese Medicine Syndromes of Postmenopausal Osteoporosis
by: Yuqing SUN, et al.
Published: (2016-12-01)